Proshares Ultrashort Nasdaq Etf Profile

BIS Etf  USD 17.19  0.08  0.46%   

Performance

Very Weak

 
Weak
 
Strong

Odds Of Distress

Low

 
High
 
Low
ProShares UltraShort is selling for under 17.19 as of the 23rd of March 2025; that is 0.46% down since the beginning of the trading day. The etf's lowest day price was 17.18. ProShares UltraShort has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 23rd of December 2024 and ending today, the 23rd of March 2025. Click here to learn more.
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the funds investment objective. ProShares UltraShort is traded on NASDAQ Exchange in the United States. More on ProShares UltraShort Nasdaq

Moving against ProShares Etf

  0.71VTV Vanguard Value IndexPairCorr
  0.62VEA Vanguard FTSE DevelopedPairCorr
  0.54GDXU MicroSectors Gold MinersPairCorr
  0.46BND Vanguard Total BondPairCorr
  0.39VO Vanguard Mid CapPairCorr

ProShares Etf Highlights

Thematic Ideas
(View all Themes)
Business ConcentrationHealth Care ETFs, Sector ETFs, Trading--Inverse Equity, ProShares (View all Sectors)
IssuerProShares
Inception Date2010-04-06
BenchmarkNasdaq Biotech Index
Entity TypeRegulated Investment Company
Average Trading Valume12,540
Asset TypeEquity
CategorySector
FocusHealth Care
Market ConcentrationDeveloped Markets
RegionNorth America
AdministratorJ.P. Morgan Investor Services Co.
AdvisorProShare Advisors LLC
CustodianJPMorgan Chase Bank, N.A.
DistributorSEI Investments Distribution Co.
Portfolio ManagerMichael Neches, Tarak Dave
Transfer AgentJPMorgan Chase Bank, N.A.
Fiscal Year End31-May
ExchangeNASDAQ
Number of Constituents18.0
Market MakerVirtu Financial
Total Expense1.97
Management Fee0.75
Country NameUSA
Returns Y T D(5.5)
NameProShares UltraShort Nasdaq Biotechnology
Currency CodeUSD
Open FigiBBG000QMCF87
In Threey Volatility32.54
1y Volatility30.84
200 Day M A16.1091
50 Day M A16.9574
CodeBIS
Updated At22nd of March 2025
Currency NameUS Dollar
In Threey Sharp Ratio(0.41)
ProShares UltraShort Nasdaq [BIS] is traded in USA and was established 2010-04-06. The fund is classified under Trading--Inverse Equity category within ProShares family. The entity is thematically classified as Health Care ETFs. ProShares UltraShort currently have 8.74 M in assets under management (AUM). , while the total return for the last 3 years was -9.9%.
Check ProShares UltraShort Probability Of Bankruptcy

ProShares UltraShort Risk Profiles

The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in ProShares UltraShort. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures.

ProShares UltraShort Against Markets

When determining whether ProShares UltraShort is a strong investment it is important to analyze ProShares UltraShort's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ProShares UltraShort's future performance. For an informed investment choice regarding ProShares Etf, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ProShares UltraShort Nasdaq. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
The market value of ProShares UltraShort is measured differently than its book value, which is the value of ProShares that is recorded on the company's balance sheet. Investors also form their own opinion of ProShares UltraShort's value that differs from its market value or its book value, called intrinsic value, which is ProShares UltraShort's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProShares UltraShort's market value can be influenced by many factors that don't directly affect ProShares UltraShort's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProShares UltraShort's value and its price as these two are different measures arrived at by different means. Investors typically determine if ProShares UltraShort is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProShares UltraShort's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.